Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Northern RNA Inc.
Calgary, Canada
A
11-50 Employees
-
Key takeaway
The company is a Canadian CDMO that specializes in the end-to-end supply of nucleic acid products, including the development of cell banks, which is crucial for cell line development. Their focus on scalable manufacturing capacity supports clients in accelerating innovation from research to production.
Reference
Product
Microbial Cell Banking | Northern RNA
PrimeVive Technologies Inc
Laval (administrative region), Canada
A
1-10 Employees
2019
Key takeaway
Primevive Technologies specializes in providing high-quality primary cells and optimized cell culture products, which are essential for cell line development. They also offer specific services to modify mouse primary cells for unique scientific needs, supporting advanced cell biology research.
Reference
Core business
Primevive Technologies | From scientists, to scientists
ExCellThera
Montreal, Canada
A
1-10 Employees
2015
Key takeaway
ExCellThera is a clinical-stage company that specializes in cell line development through advanced cell expansion and engineering techniques. Their focus on modifying various cell lines supports innovative therapies for hematological malignancies and other diseases.
Reference
Core business
ExCellThera | Cell Expansion and Rejuvenation
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Centre for Commercialization of Regenerative Medicine
Canada
A
101-250 Employees
2011
Key takeaway
CCRM specializes in the development and commercialization of cell and gene therapies, making it a key player in the field of cell line development. With a team of over 220 employees, including 55+ PhDs, CCRM offers specialized expertise and a comprehensive approach to streamline the process from lab to manufacturing.
Reference
Core business
CCRM | Commercializing Living Therapies
CCRM brings together stakeholders, expertise, infrastructure and funding to accelerate the development and commercialization of regenerative medicines.
Morphocell Technologies
Montreal, Canada
A
- Employees
2018
Key takeaway
Morphocell Technologies is focused on developing cell therapies and engineered tissues, particularly through its innovative platform that utilizes allogeneic stem cell-derived engineered tissues for organ replacement. Their first product, ReLiver®, addresses acute liver failure and represents a significant advancement in liver cell therapy.
Reference
Product
Morphocell Technologies | Products
InsideScientific
London, Canada
A
1-10 Employees
2013
Key takeaway
The company presents a standardized human induced pluripotent stem cell line and its differentiation into neural cells, which is relevant for disease modeling and assay development in the context of cell line development. This expertise highlights their capabilities in advancing research through innovative cell line technologies.
Reference
Product
Animal Facility Management Software Archives - InsideScientific
Evik Diagnostic Innovations Inc
Ottawa, Canada
A
1-10 Employees
2010
Key takeaway
Evik Diagnostics specializes in the development and manufacturing of Single-Assay lyophilized beads, providing ready-to-use reagents that are ambient temperature stable. Their expertise and strategic partnerships enable them to efficiently support the development and optimization of diagnostic assays.
Reference
Service
Development - Evik Diagnostics
Cell Therapy Group
Vancouver, Canada
A
1-10 Employees
2008
Key takeaway
Cell Therapy Group (CTG) specializes in providing business-focused services within the cell-based regenerative medicine sector, highlighting its extensive experience with both startups and major pharmaceutical companies.
Reference
Core business
Cell Therapy Group
RJH Biosciences
Edmonton, Canada
A
11-50 Employees
2016
Key takeaway
RJH Biosciences specializes in developing innovative transfection reagents and delivery systems tailored for various human cells and cell lines, which is crucial for effective cell line development. Their focus on enhancing transfection efficiency for mRNA and other nucleic acids supports both biomedical research and therapeutic applications.
Reference
Product
mRNA Transfection Reagents - RJH BioSciences
Attachment dependents such as MCF-7, MDA-MB-436, MDA-MB-231 cells, and suspension cell lines such as K562 and THP-1 cells Optimized for mRNA transfection in transient protein expression
panCELLa
Mississauga, Canada
A
1-10 Employees
2015
Key takeaway
Pluristyx is focused on advancing cellular therapeutics, particularly in the realm of iPSC-derived treatments. Their panCELLa Platform enhances stem cell research and development, which may be highly relevant for those interested in cell line development.
Reference
Service
Technology Licensing – Pancella
Technologies which have been searched by others and may be interesting for you:
When exploring the Cell Line Development industry in Canada, several key considerations come into play. Regulatory compliance is paramount, as Health Canada oversees the approval processes and ensures that companies adhere to strict guidelines regarding safety and efficacy. Understanding these regulations is crucial for new entrants and existing companies alike. The competitive landscape is also significant, with a mixture of established firms and innovative startups striving for market share. Challenges in this industry may include high development costs, lengthy timelines for cell line optimization, and the need for specialized expertise. However, opportunities abound due to Canada's robust biotech ecosystem, which is supported by government initiatives and funding opportunities aimed at fostering innovation. Environmental concerns, particularly related to waste management and bioethics, must also be considered, as public scrutiny increases around biotechnology practices. Furthermore, the global market relevance of Canadian cell line development is growing, driven by increased demand in the pharmaceutical and biotechnology sectors for personalized medicine and advanced therapies. Networking within industry associations and attending relevant conferences can provide valuable insights and connections. By thoroughly researching these aspects, individuals can make informed decisions regarding potential investments or career opportunities in this dynamic field.
Some interesting numbers and facts about your company results for Cell Line Development
| Country with most fitting companies | Canada |
| Amount of fitting manufacturers | 319 |
| Amount of suitable service providers | 314 |
| Average amount of employees | 1-10 |
| Oldest suiting company | 2008 |
| Youngest suiting company | 2019 |
Some interesting questions that has been asked about the results you have just received for Cell Line Development
What are related technologies to Cell Line Development?
Based on our calculations related technologies to Cell Line Development are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on Cell Line Development?
The most represented industries which are working in Cell Line Development are Biotechnology, Other, IT, Software and Services, Pharmaceuticals, Healthcare
How does ensun find these Cell Line Development Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.